We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$13.8M
Cap. Flow
-$371K
Cap. Flow %
-0.14%
Top 10 Hldgs %
49.35%
Holding
208
New
7
Increased
11
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$930K
2
UL icon
Unilever
UL
+$381K
3
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$367K
4
DXCM icon
DexCom
DXCM
+$322K
5
FND icon
Floor & Decor
FND
+$290K

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$487K
2
VZ icon
Verizon
VZ
+$317K
3
SPLK
Splunk Inc
SPLK
+$314K
4
NVS icon
Novartis
NVS
+$292K
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$231K

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 8.06%
3 Financials 7.83%
4 Consumer Discretionary 6.21%
5 Industrials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
76
Medtronic
MDT
$107B
$695K 0.26%
5,601
– –
INFO
77
DELISTED
IHS Markit Ltd. Common Shares
INFO
$689K 0.26%
6,114
– –
MT icon
78
ArcelorMittal
MT
$50.4B
$679K 0.26%
21,863
– –
WSM icon
79
Williams-Sonoma
WSM
$26.7B
$678K 0.26%
8,488
– –
GWW icon
80
W.W. Grainger
GWW
$65.3B
$676K 0.26%
1,543
– –
ULTA icon
81
Ulta Beauty
ULTA
$20.4B
$660K 0.25%
1,908
– –
ZBRA icon
82
Zebra Technologies
ZBRA
$12.4B
$654K 0.25%
1,235
– –
PG icon
83
Procter & Gamble
PG
$343B
$641K 0.24%
4,751
– –
UBER icon
84
Uber
UBER
$134B
$641K 0.24%
12,787
– –
KMB icon
85
Kimberly-Clark
KMB
$36.4B
$635K 0.24%
4,750
– –
VZ icon
86
Verizon
VZ
$194B
$631K 0.24%
11,262
-5,524
-33% -$317K
SMFG icon
87
Sumitomo Mitsui Financial
SMFG
$166B
$630K 0.24%
91,423
– –
FIS icon
88
Fidelity National Information Services
FIS
$21.5B
$624K 0.24%
4,406
– –
RYAAY icon
89
Ryanair
RYAAY
$29.5B
$622K 0.23%
14,368
– –
DIOD icon
90
Diodes
DIOD
$4B
$619K 0.23%
7,763
– –
RJF icon
91
Raymond James Financial
RJF
$32.5B
$617K 0.23%
7,122
– –
RPM icon
92
RPM International
RPM
$13.7B
$604K 0.23%
6,808
– –
BTI icon
93
British American Tobacco
BTI
$132B
$603K 0.23%
15,346
-2,799
-15% -$110K
JNK icon
94
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
$601K 0.23%
5,468
+60
+1% +$6.54K
PANW icon
95
Palo Alto Networks
PANW
$264B
$596K 0.22%
9,642
– –
RTX icon
96
RTX Corp
RTX
$287B
$593K 0.22%
6,950
– –
AON icon
97
Aon
AON
$77.3B
$586K 0.22%
2,454
– –
AAP icon
98
Advance Auto Parts
AAP
$3.37B
$584K 0.22%
2,847
– –
DIS icon
99
Walt Disney
DIS
$165B
$577K 0.22%
3,283
– –
MAS icon
100
Masco
MAS
$16B
$543K 0.2%
9,215
– –
2 3
4
5 6

Similar funds

SHFA
SS&H Financial Advisors Troy, Michigan $343M AUM 28.43% 1-Year Est. Return
YCG
Yeomans Consulting Group Marietta, Georgia $341M AUM 22.92% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
LODC
Lanham O'Dell & Company Hurricane, West Virginia $347M AUM 20.92% 1-Year Est. Return
OFS
Oldfather Financial Services Kearney, Nebraska $336M AUM 15.03% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
PPH
Pure Portfolios Holdings Lake Oswego, Oregon $332M AUM 20.54% 1-Year Est. Return
TPW
Transatlantique Private Wealth New York $319M AUM 22.93% 1-Year Est. Return

Covenant Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Covenant Partners held 208 positions worth $265M, up 5.5% from $251M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Covenant Partners's Q2 2021 filing shows 7 new, 11 increased, 28 reduced and 7 closed positions. Its largest new stake was Unilever: 5,724 shares worth $377K. The largest sale was Takeda Pharmaceutical, an estimated $487K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Covenant Partners's largest Q2 2021 buy was Unilever: 5,724 shares worth $377K.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q2 2021, an estimated $930K increase.
  • Covenant Partners's biggest Q2 2021 reduction was Takeda Pharmaceutical, cutting an estimated $487K.
  • Covenant Partners fully exited BioMarin Pharmaceuticals in Q2 2021, selling an estimated $231K.
  • Covenant Partners's ten largest holdings make up 49% of its $265M portfolio in Q2 2021.
  • Covenant Partners opened 7 new positions and closed 7 in Q2 2021.
  • Covenant Partners's portfolio value rose 5.5% quarter-over-quarter to $265M.

Based on Covenant Partners's 13F filing for Q2 2021, filed 2 Aug 2021.